BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12182161)

  • 1. Understanding sexual activity defined in the HEDIS measure of screening young women for Chlamydia trachomatis.
    Tao G; Walsh CM; Anderson LA; Irwin KL
    Jt Comm J Qual Improv; 2002 Aug; 28(8):435-40. PubMed ID: 12182161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Significant Impact of Different Insurance Enrollment Criteria on the HEDIS Chlamydia Screening Measure for Young Women Enrolled in Medicaid and Commercial Insurance Plans.
    Patel CG; Tao G
    Sex Transm Dis; 2015 Oct; 42(10):575-9. PubMed ID: 26372930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of data collection for the HEDIS performance measure on chlamydia screening in an MCO.
    Wei F; Walsh CM
    Am J Manag Care; 2003 Sep; 9(9):585-93. PubMed ID: 14527104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding sexual activity and Chlamydia testing rate based on linked national survey and Medicaid claims data.
    Tao G; Hua J; Chen JL
    PLoS One; 2015; 10(4):e0122927. PubMed ID: 25875858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating chlamydia screening coverage: a comparison of self-report and health care effectiveness data and information set measures.
    Khosropour CM; Broad JM; Scholes D; Saint-Johnson J; Manhart LE; Golden MR
    Sex Transm Dis; 2014 Nov; 41(11):665-70. PubMed ID: 25299413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia screening coverage estimates derived using healthcare effectiveness data and information system procedures and indirect estimation vary substantially.
    Broad JM; Manhart LE; Kerani RP; Scholes D; Hughes JP; Golden MR
    Sex Transm Dis; 2013 Apr; 40(4):292-7. PubMed ID: 23486493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of the American College of Obstetricians and Gynecologists Guideline Changes in Pap Tests on Annual Chlamydia Test Rates.
    Hsieh HL; Huppert J; Patel CG; Tao G
    J Adolesc Health; 2017 Oct; 61(4):440-445. PubMed ID: 28754585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health and cost-benefits of chlamydia screening in young women.
    Mangione-Smith R; O'Leary J; McGlynn EA
    Sex Transm Dis; 1999 Jul; 26(6):309-16. PubMed ID: 10417017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of data collection for the HEDIS performance measure on chlamydia screening in a MCO.
    Scholle SH; Wong L; Roski J
    Am J Manag Care; 2003 Nov; 9(11):713, 776; author reply 776. PubMed ID: 14626469
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for chlamydia in adolescents and young women.
    Mangione-Smith R; McGlynn EA; Hiatt L
    Arch Pediatr Adolesc Med; 2000 Nov; 154(11):1108-13. PubMed ID: 11074851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young Adults' Access to Insurance Through Parents: Relationship to Receipt of Reproductive Health Services and Chlamydia Testing, 2007-2014.
    Loosier PS; Hsieh H; Cramer R; Tao G
    J Adolesc Health; 2018 Nov; 63(5):575-581. PubMed ID: 30115507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):362-5. PubMed ID: 19373196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Chlamydia screening rates by using reported sexually transmitted disease tests for sexually active women aged 16 to 25 years in the United States.
    Tao G; Tian LH; Peterman TA
    Sex Transm Dis; 2007 Mar; 34(3):180-2. PubMed ID: 16865052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia testing patterns for commercially insured women, 2008.
    Tao G; Hoover KW; Kent CK
    Am J Prev Med; 2012 Apr; 42(4):337-41. PubMed ID: 22424245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance indicators in women's health: incorporating women's health in the health plan employer data and information set (HEDIS).
    McKinley ED; Thompson JW; Briefer-French J; Wilcox LS; Weisman CS; Andrews WC
    Womens Health Issues; 2002; 12(1):46-58. PubMed ID: 11786292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia screening among sexually active young female enrollees of health plans--United States, 1999-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(42):983-5. PubMed ID: 15514579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexually transmitted infections and use of sexual health services among young Australian women: women's health Australia study.
    Schofield MJ; Minichiello V; Mishra GD; Plummer D; Savage J
    Int J STD AIDS; 2000 May; 11(5):313-23. PubMed ID: 10824940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2009 cervical cytology guidelines and chlamydia testing among sexually active young women.
    Tao G; Hoover KW; Kent CK
    Obstet Gynecol; 2010 Dec; 116(6):1319-1323. PubMed ID: 21099597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEDIS audits: meeting the challenge.
    Bishop W; Park K; Rector J; Faulkner M
    J Healthc Qual; 1998; 20(6):10-5; quiz 15, 48. PubMed ID: 10351210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receipt of Selected Preventive Health Services for Women and Men of Reproductive Age - United States, 2011-2013.
    Pazol K; Robbins CL; Black LI; Ahrens KA; Daniels K; Chandra A; Vahratian A; Gavin LE
    MMWR Surveill Summ; 2017 Oct; 66(20):1-31. PubMed ID: 29073129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.